Influence of treatment and response status on infection risk in multiple myeloma
- 1 December 1981
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 71 (6), 935-940
- https://doi.org/10.1016/0002-9343(81)90303-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Infections in Patients With Multiple MyelomaArchives of Internal Medicine, 1980
- Localized and indolent myelomaBlood, 1980
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1- nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myelomaBlood, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Infections Complicating Multiple Myeloma and Chronic Lymphocytic LeukemiaArchives of Internal Medicine, 1973
- Combination chemotherapy for multiple myelomaCancer, 1972
- Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemiaAmerican Journal Of Medicine, 1963
- A Review of Fifty-One Cases of Multiple MyelomaA.M.A. Archives of Internal Medicine, 1959